About this episode
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
Up next
Nov 20
Delayed but not denied: justice for the Rohingyas
After decades of persecution, and seven years after the case was first brought before the UN’s highest court, judges ruled that Myanmar has committed genocide against the muslim minority. AI has facilitated new methods of cyber-crime, but for tech giants it has also created new o ...
27m 18s
Nov 19
Racing ahead: Anthropic’s big IPO
The leading AI lab is expected to raise over $80bn, the largest sum ever raised at an initial public offering. Where does this leave its rival OpenAI? The countries profiting from China and America’s battle for the world’s critical minerals. And why the colour of your rice might ...
22m 31s
Recommended Episodes
Sep 2025
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...
22m 31s
Apr 2021
AZ Good as it Gets?
An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ...
32m 39s
Jun 2023
AstraZeneca could spin off China business
<p>AstraZeneca has drawn up plans to break out its China business, and France is challenging a German-led plan to build up Europe’s air defences. Plus, US businesses are cutting back on their investments in diversity and inclusion. </p><br><p><strong>Mentioned in this p ...
8m 9s
Apr 2020
The search for a remedy
As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...
20m 17s
Sep 2024
Who audits the auditors?
<p>The UK blocks some arms shipments to Israel, audit firms are fighting against new oversight rules in the US, and the same technology that brought us Covid-19 vaccines could also be used to fight cancer. Plus, the Oasis revival tour is so popular it triggered a UK investigation ...
10m 39s
Sep 2023
Xi 'Has His Hands Full', UK-China Spying & Far Right Strength In Europe
<p>On today's podcast:<br>(1) President Biden says China's economic challenges make a Taiwan invasion unlikely.</p> <p>(2) The UK's Prime Minister confronts the Chinese premier over a Parliamentary spying arrest.</p> <p>(3) Costs for UK tenants expected to soar by a quarter over ...
16m 36s
May 2023
US sues to block drug merger
<p>The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said it repelled an unprecedented barrage of Russian missiles over Kyiv. ...
9m 43s
Mar 2021
EU countries to restart AstraZeneca use, Biden's hardline on China, airline lift-off
<p>Europe’s biggest countries are set to resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator said the jab was safe, and the US is taking a tough stance as members from the Biden administration meet with Chinese officials in Alaska. Plus, the FT’s ...
10m 31s
Oct 2021
Sick Money (Pt 2): How Big Pharma made a killing from the pandemic
The second of two episodes this week, taking a deep dive into the pharmaceutical industry.Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vaccines for ot ...
24m 39s